Close Menu

NEW YORK (GenomeWeb) – Roche reported on Thursday a 6 percent increase in revenues from its Diagnostics division for the first half of 2016, driven by strong growth of all diagnostics businesses except diabetes care.

In total, the Swiss pharmaceutical and diagnostics company reported CHF 25.02 billion ($25.5 billion) in half-year sales, a 6 percent increase compared to half-year sales of CHF 23.59 billion in 2015. On a constant currency basis, total sales grew 5 percent in the first half of 2016.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Dec
02
Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.